Successful selective reduction of a heterotopic cesarean scar pregnancy in the second trimester: a case report and review of the literature by Haiyan Yu et al.
CASE REPORT Open Access
Successful selective reduction of a
heterotopic cesarean scar pregnancy in the
second trimester: a case report and review
of the literature
Haiyan Yu1,4, Hong Luo2,4*, Fumin Zhao3,4, Xinghui Liu1,4 and Xiaodong Wang1,4*
Abstract
Background: Heterotopic cesarean scar pregnancy is a cesarean scar pregnancy combined with an intrauterine
pregnancy that predisposes a woman to life-threatening complications such as uterine rupture and massive bleeding.
Preservation of the intrauterine pregnancy in heterotopic cesarean scar pregnancy is a great challenge.
Case presentation: We report a case of a 33-year-old woman with heterotopic cesarean scar pregnancy after
IVF-embryo transfer (ET). Expectant management was carried out with early diagnosis of heterotopic cesarean
scar pregnancy (HCSP), and selective fetal reduction of cesarean scar pregnancy (CSP) was performed by
ultrasound-guided intrathoracic injection of potassium chloride (KCl) at 16 + 4 weeks of gestation due to aggravation
of CSP. Preservation of the intrauterine pregnancy was successful and a healthy baby was delivered by cesarean
section at 37 + 6 weeks of gestation.
Conclusions: Heterotopic cesarean scar pregnancy is an extremely rare form of heterotopic pregnancy. Patients should
be appropriately counseled regarding the different treatment options available. An ultrasound-guided injection
of potassium chloride may constitute a safe, minimally invasive and reliable way to terminate the heterotopic
gestation and preserve the intrauterine pregnancy. Intensive management should be performed during the
ongoing pregnancy and cesarean section.
Keywords: Heterotopic cesarean scar pregnancy, Potassium chloride, Selective fetal reduction, Expectant
management
Background
Cesarean scar pregnancy (CSP) is one of the rarest forms
of ectopic pregnancy, located in the scar of a previous
cesarean section. The incidence of CSP has been esti-
mated to be between 1:2216 and 1:1688 [1–4]. CSP results
in life-threatening complications such as uterine rupture
and catastrophic hemorrhage, which may, in turn, be asso-
ciated with maternal and fetal morbidity and mortality [5].
Therefore, immediate intervention (sometimes including
hysterectomy), must be performed [6].
Heterotopic pregnancy (HP) is defined as the simultan-
eous presence of intrauterine pregnancy and ectopic preg-
nancy, which is very rare but a potentially life-threatening
condition. HP can be spontaneous or the subsequence of
assisted reproductive technology (ART), with the
frequency of spontaneous heterotopic pregnancy reported
as between 1 in 50,000 to 1 in 10,000 [7, 8] and the inci-
dence in ART is 0.2–1% [9].
Heterotopic cesarean scar pregnancy (HCSP) is cesarean
scar pregnancy combined with an intrauterine pregnancy
that predisposes a woman to life-threatening complica-
tions such as uterine rupture and massive bleeding. The
incidence of HCSP during spontaneous cycles is extremely
low. However, with the increasing incidence of cesarean
section and extensive use of assisted reproductive
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technologies, the prevalence of heterotopic cesarean scar
pregnancy (CSP) is expected to rise. Preservation of an
intrauterine pregnancy in HCSP is a great challenge, and
only isolated case reports of such pregnancies have been
published in the literature, with the first case of HCSP
published by Salomon et al. in 2003 [10]. Despite the lack
of a standard treatment protocol, expectant management
and medical and surgical treatment modalities have
recently been suggested. In fact, urgent hysterectomy may
be required in patients with uncontrolled hemorrhage and
uterine rupture.
We used a list of keywords, including “Ectopic preg-
nancy,” “Cesarean section scar,” and “Heterotopic cesarean
scar pregnancy,” to perform an extensive search of the lit-
erature; and we found fewer than 25 cases of HCSP having
been reported. In the present article, we report 1 case of
twin HCSP in a patient after IVF-embryo transfer (ET).
We performed transabdominal intrathoracic injection of
KCl into a CSP fetus at 16 + 4 weeks of gestation and the
intrauterine pregnancy was successfully preserved. In
addition, we performed a Medline search and reviewed
the English-language literature for similar cases; and these
are summarized herein. Written informed consent was
obtained from the couple before the procedure and manu-
script publication. The treatment procedure followed
ethical principles, all data were collected from chart
reviews, and approval was obtained from the Institutional
Review Board.
Case presentation
A 33-year-old Tibetan woman, gravida 2, para 1, was
admitted because of the abnormal location of one of the
two gestational sacs of a twin pregnancy; she had previ-
ously undergone transverse lower segment cesarean
section 7 years earlier. The patient underwent IVF-ET and
3 embryos were transferred to the uterus; a positive preg-
nancy test was noted 14 days after embryo transfer. Four
weeks after embryo transfer, transabdominal ultrasonog-
raphy revealed 1 intrauterine gestational sac. However, the
patient did not adhere to the physician’s suggestion of a
follow-up 1 week later.
Sixty days after embryo transfer, transvaginal ultrason-
ography revealed a dichorionic twin pregnancy with nor-
mal cardiac activity and 1 gestational sac situated in the
uterine fundus; the other was located lower, immediately
over the cesarean section scar, with a thin myometrium
of 4 mm in thickness (Fig. 1). The patient manifested no
abdominal pain and/or vaginal bleeding. A diagnosis of
heterotopic cesarean scar pregnancy was then made, but
the couple refused medical intervention.
A follow-up was pursued 7 days later, with both
fetuses showing normal fetal cardiac activity and crown–
rump length measurements (55 and 48 mm, respectively)
that were in accordance with a fetus at 12 + 1 weeks of
gestation; 1 fetus was in the upper fundus, whereas the
second was still located at the level of the internal os. The
ectopic placenta covered the internal cervical os and the
cesarean section scar, which was in close proximity to the
maternal bladder and which showed the presence of peri-
trophoblastic vascularity upon Doppler examination.
When the patient was transferred to our department,
because of the potential of uterine rupture and cata-
strophic hemorrhage, we extensively counselled the
couple regarding the condition, its risks, and the man-
agement options for heterotopic pregnancy. We sug-
gested to the couple the use of selective reduction of the
heterotopic cesarean scar pregnancy as soon as possible.
The couple, however, refused and preferred expectant
Fig. 1 Diagnosis of cesarean heterotopic pregnancy via transvaginal ultrasonography at 11 + 1 weeks’ gestation. Myometrial layer of cesarean scar 4 mm
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management; close monitoring was then performed
without patient bleeding and lower abdominal pain. At
16 + 3 weeks of gestation, transabdominal ultrasonog-
raphy revealed a thin myometrial layer of the cesarean
section scar (3.8 mm thick) and complete placenta pre-
via (Fig. 2). Massive bleeding and/or uterine rupture
during an ongoing pregnancy with expectant manage-
ment was discussed again with the couple, and the pa-
tient opted for selective termination of the abnormally
located fetus; this was then accomplished at 16 + 4 weeks
of gestation by ultrasound-guided intrathoracic injection
of 1 mL of 10% KCl using a 20-G needle inserted trans-
abdominally under local anaesthesia with lidocaine.
Upon follow-up, ultrasonography was repeated every two
weeks. Although fetal biometric parameters of the on-
going pregnancy were normal, the ectopic placenta still
showed total placenta previa and placenta accrete. At
37 weeks’ gestation, a written informed consent was ob-
tained from the couple undergoing MRI to evaluate the
placenta. MR image showed heterotopic complete pla-
centa previa and placenta accreta, marked focal thinning
of myometrium at the region of cesarean scar. The in-
ternal cervical os was covered completely by placenta and
dead fetus (Fig. 3).
At 37 + 6 weeks of gestation the baby was delivered by
elective cesarean section. Before the operation, we exten-
sively counseled the couple about the possibility of CS
hysterectomy due to total placenta previa and pla-
centa accreta. We noted intraoperatively that profuse
vascularization covered the lower uterine segment,
that the bladder adhered to the anterior lower segment,
and that the mass of HCSP was palpated at the lower
uterine segment and bulged toward the vesicoperitoneal
reflection. A healthy male baby weighing 2890 gm was
delivered through a transverse incision 1 cm above this
mass, with Apgar scores of 10 and 10 at 1 and 5 min,
respectively. When the dead fetus and placental mass of
the HCSP were removed, profuse bleeding due to placenta
accreta ensued, and bleeding was controlled by partial
excision of the anterior lower uterine segment along with
myometrial sutures and uterine packing with gauze.
Three-and-one-half units of packed red blood cells were
then transfused. The postoperative period was uneventful
and the patient and the baby were discharged 6 days after
the operation. The pathologic results of the excised
anterior lower uterine segment revealed placenta accreta,
showing chorionic villi in direct contact with myometrial
smooth muscle fibers.
Discussion
Cesarean scar pregnancy may have a silent clinical
course or present with specific clinical symptoms such
as abnormal vaginal bleeding and/or abdominal pain or
acute abdominal pain due to uterine rupture. Hetero-
topic cesarean scar pregnancy (HCSP) is unusual as it is
a CSP in combination with an intrauterine pregnancy.
Due to its rarity, there is no standard treatment protocol
for HCSP.
Early diagnosis of CSP in the first trimester may allow
the preservation of viability for the intrauterine fetus
and avoid maternal morbidity in HCSP. High-resolution
vaginal ultrasonography is the preferred diagnostic
Fig. 2 Heterotopic complete placenta previa and placenta accreta at ultrasonography at 16+3 weeks’ gestation
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method for HCSP, and the mean gestational age at CSP
diagnosis is reported to be 7.5±2.5 weeks [11]. Ouyang et
al. [4] showed that the gestational age ranged from 5
weeks and 3 days to 7 weeks and 4 days in CSP and
from 5 weeks and 6 days to 7 weeks and 4 days in
HCSP using transvaginal color Doppler sonography.
Treatment options for cesarean scar pregnancy include
open surgery, operative hysteroscopy and curettage, sys-
temic or local methotrexate (MTX), transvaginal embryo
aspiration, and potassium chloride injection [10–12].
The great challenge in the management of HCSP is to
preserve the concurrent intrauterine pregnancy, which
makes the therapeutic management more difficult and
may not be the same as management of CSP.
Only a few cases of HCSP have been reported, and there
is currently no standard treatment protocol for HCSP.
Therefore, in the present study, we conducted a search and
review of the literature pertaining to HCSP. To the best of
our knowledge, a total of 23 cases of HCSP have been
reported in the English literature [2, 4, 10, 12–26], and the
results are summarized in Additional file 1: Table S1. The
reported treatments included conservative management,
fetal reduction by potassium chloride, laparoscopic exci-
sion, aspiration of embryonic or ectopic gestational sac,
hysteroscopy with directed evacuation, injection of a
mixture of MTX and KCl, or laparotomic excision.
Expectant management
The literature includes seven case reports of HCSP with
expectant management [4, 21, 25], only one of which
was a spontaneous pregnancy; the others developed after
in-vitro fertilization. Five cases exhibited vaginal bleed-
ing and/or abdominal pain and 4 cases delivered live
births at 35–37 weeks of gestation. In Bai’s report, dur-
ing the expectant management severe vaginal bleeding
occurred at 8 + 4 weeks of gestation, and this resulted in
blood loss anemia (Hb 68 g/L) and a blood transfusion;
and subsequently, spontaneous abortion of the CSP
occurred at 9 + 1 weeks [21]. Ouyang et al. [4] reported
that the success rate with expectant management in
cases with a non-viable CSP was 100% (5/5); however,
we do not know the maternal morbidity in 3 cases, as 2
cases terminated pregnancy at 14 weeks and 6 months,
and 1 case was uneventful at the time of the author’s
report (18 weeks of gestation). An emergency cesarean
section was performed at 35 weeks in 1 patient due to
massive hemorrhage caused by complete placenta previa.
Kim et al. reported the only example of HCSP with
expectant management and live births of 2 vital babies
at 37.3 weeks; however, severe postpartum bleeding due
to placenta accreta occurred and bleeding was controlled
by complete excision of the anterior lower uterine seg-
ment along with bilateral uterine artery ligation [25].
Therefore, expectant management might be a choice for
HCSP, especially in cases with a non-viable CSP.
Selective fetal reduction
Suction aspiration of cesarean scar pregnancy
Suction aspiration of cesarean scar pregnancy under vagi-
nal ultrasonography is another procedure described in the
literature [12, 18, 24]. Gupta et al. performed the proced-
ure at 6 + 3 weeks and suction termination of pregnancy
was performed at 13 weeks due to trisomy 13 detected
[18]. In Hsieh’s report, treatment by embryo aspiration
was done at 6 weeks and the concurrent intrauterine twin
pregnancy was preserved successfully with delivery at
32 weeks due to preterm labor [12]. Lui et al. reported the
first case of treatment for heterotopic CSP using repeated
transvaginal aspiration of the gestational sac (which was
complicated by arteriovenous malformation ([AVM]), and
cesarean section at 37 weeks of gestation and uterine ar-
tery embolization (UAE) due to massive bleeding [24].
Medical treatment in selective fetal reduction
Salomon et al. reported that the first case of HCSP was
successfully treated with potassium chloride under sono-
graphic guidance [10]. Subsequently, eight authors [2, 4,
13, 14, 16, 20, 22, 23] reported selective embryo reduc-
tion performed using transvaginal ultrasound-guided
KCl injection or potassium chloride and methotrexate
(MTX) injection into the ectopic gestational sacs between
Fig. 3 Magnetic resonance imaging findings at 37 weeks’ gestation.
Heterotopic complete placenta previa and placenta accrete, dead
fetus and placenta covering the internal cervical os (white arrow).
Thin myometrial layer of cesarean scar (1.3 mm, black arrow)
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6 and 10 weeks of gestation, with no complications arising
during the procedures. Most pregnancies were uneventful
throughout, except for one patient where some vaginal
bleeding and uterine contractions occurred at 28 and
34 weeks, respectively. Among the cases reported, only 1
case was delivered at term, 5 cases at 34–36 weeks, 2 cases
at 30–31weeks and 1 case was terminated at 14 weeks.
Five patients were complicated with a post-partum
hemorrhage, in which one was managed with hypogastric
artery ligation and subtotal hysterectomy [22], and 1 with
bilateral internal iliac artery ligation [14]. There were eight
case reports with potassium chloride injections into the
HSCP; interestingly, Litwicka et al. [20] injected a potas-
sium chloride and methotrexate mixture into the ectopic
gestational sacs in a triplet, which is the first case of triplet
HCSP where 2 gestational sacs implanted in the cesarean
scar. The baby’s situation in Litwicka’s report was compli-
cated with Miller syndrome. Although this is a genetic
condition inherited as an autosomal recessive trait, poten-
tial teratogenic effects of MTX on the intrauterine fetus
should be considered in the treatment of local injection
into heterotopic pregnancies; and MTX-related teratogen-
icity to the surviving fetus has been reported [27–29].
When cardiac activity is detected in a CSP, selective em-
bryo reduction in situ is normally chosen, and intracardiac
injection of potassium chloride is typically used (REF?). In
addition, since retained placental tissue subsequent to fetal
reduction might lead to obstetric complications, this mat-
ter should be discussed with the patient. According to the
CSP literature, seven babies have been born prematurely
due to premature rupture of the membranes, preterm
labor, hemorrhage, abruptio placentae, or uterine rupture.
Surgical removal of the HCSP
An ectopic pregnancy located within cesarean section scar
tissue has a high risk of rupture and bleeding. The major
problem after medical approaches may be the difficulty of
procuring a strong lower segment in the presence of a con-
current intrauterine pregnancy. Urgent hysterectomy may
then be required in patients with uncontrolled hemorrhage
and uterine rupture; and in order to improve the perinatal
outcome of the intrauterine pregnancy, some authors surgi-
cally removed the placental tissue and repaired the myome-
trium (obviating some side effects of medical treatment).
All cases reported thus far carried uneventful prenatal
courses and the pregnant women delivered live babies at
term. Demirel et al. performed a laparoscopic excision of a
scar pregnancy at 6 weeks and 5 days of pregnancy; postop-
erative follow-up was uneventful and the intrauterine fetus
was delivered by cesarean section at 38 weeks of gestation
[15]. Wang et al. reported hysteroscopic management of
heterotopic cesarean scar pregnancy under ultrasound
guidance at 7 weeks of gestation, with the baby delivered at
39 weeks of pregnancy [17]. Armbrust et al. successfully
excised a HSP by laparotomy at 7 weeks of gestation, with
a subsequent uncomplicated cesarean section and delivery
of a healthy baby at 37 weeks of pregnancy [26].
Although surgical procedures are suggested as an alter-
native treatment for HCSP, complications and risks with
surgery should be evaluated, including anesthesia acci-
dents and complications, operative blood loss in anatomic
dissection and excision trimming of unhealthy tissues,
intrauterine embryo disturbance due to the distending
medium used during hysteroscopy, and antepartum
spotting or uterine rupture during an ongoing pregnancy.
In the present case we did not choose the surgical
approach due to placenta previa, with a major ectopic
mass needing to be removed, potentially only increasing
procedure-related complications and exposing the intra-
uterine pregnancy to serious risks. At the time of diagno-
sis, the lack of symptoms and the couple’s desire provided
the option of conservative management. Although the pa-
tient was asymptomatic, due to extant placenta previa and
placenta accreta and the high risk for bleeding and uterine
rupture, we decided at 16 + 4 weeks of gestation to inject
KCl selectively into the CSP rather than using a conserva-
tive management strategy. This action successfully ter-
minated the CSP and the intrauterine pregnancy was
successfully preserved. The serial follow-up ultrasounds
still revealed placenta previa and placenta accreta, and
suggested a local blood circulation; and significant blood
loss (1800 ml) occurred during the cesarean section due
to the retained trophoblastic tissue. This condition was
similar to that described by Wang et al. [14] and by
Gyamfi et al. [30]. Although local injection of MTX may
reduce the risks of persistent trophoblastic tissue, we did
not choose to inject MTX due to the possibility of MTX-
related teratogenicity to the intrauterine pregnancy.
Conclusions
Heterotopic cesarean scar pregnancy is an extremely
rare form of heterotopic pregnancy. The desire to pre-
serve the intrauterine pregnancy in cases of HCSP is a
great challenge, and no universal management guidelines
have been established. The current lack of data with
respect to best practices should encourage publication of
more individual case reports and the establishment of
further multicenter studies in the future. Importantly,
patients must be appropriately counseled regarding the
different treatment options available.
Based on previously reported cases and our case, injec-
tion of potassium chloride may be a safe, minimally
invasive and reliable way to terminate the heterotopic
gestational sac and preserve the intrauterine pregnancy.
As retained gestational tissue may contribute to uterine
rupture and massive uterine bleeding during an ongoing
pregnancy and cesarean section, intensive management
should be performed.
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